Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: Identification of a new biglycan cleavage site

Arthritis Research and Therapy

Volumn 8, Issue 1, 2006, Pages

  Monfort, Jordi ^a   Tardif, Ginette ^a   Reboul, Pascal ^a   Mineau, François ^a   Roughley, Peter ^b   Pelletier, Jean Pierre ^a   Martel Pelletier, Johanne ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BGN PROTEIN, HUMAN; BIGLYCAN; COLLAGENASE; COLLAGENASE 3; DCN PROTEIN, HUMAN; DECORIN; FIBROMODULIN; KERATAN SULFATE; LEUCINE; LUMICAN; MMP13 PROTEIN, HUMAN; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; RECOMBINANT PROTEIN; SCLEROPROTEIN;

ADULT; AGED; CASE CONTROL STUDY; CHEMISTRY; HUMAN; KNEE OSTEOARTHRITIS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIGLYCAN; CASE-CONTROL STUDIES; CHONDROITIN SULFATE PROTEOGLYCANS; COLLAGENASES; DECORIN; EXTRACELLULAR MATRIX PROTEINS; HUMANS; KERATAN SULFATE; LEUCINE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROTEOGLYCANS; RECOMBINANT PROTEINS;

EID: 70350516243     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1873     Document Type: Article

References (47)

1. Heinegard D, Bayliss M, Lorenzo P: Pathogenesis of structural changes in the osteoarthritic joint. In Osteoarthritis Edited by: Brandt KD, Doherty M, Lohmander SL New York: Oxford University Press Inc; 2003:73-92.
2. Kjellen L, LSndahl U: Proteoglycans: structures and interactions. Annu Rev Biochem 1991, 60:443-475.
3. Poole AR: Cartilage in Health and Disease. In Arthritis and Allied Conditions. Edited by: Koopman WJ, Moreland LW Philadelphia: Lippincott, Williams & Wilkins; 2005:223-269.
4. Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, Birch DG, Bergen AA, Prinsen CF, Polomeno RC, Gal A, et al.: Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 2000, 26:319-323.
5. Knudson CB, Knudson W: Cartilage proteoglycans. Semin Cell Dev Biol 2001, 12:69-78.
6. Hedlund H, Mengarelli-Widholm S, Heinegard D, Reinholt FP, Svensson O: Fibromodulin distribution and association with collagen. Matrix Biol 1994, 14:227-232.
7. Lorenzo P, Aspberg A, Onnerfjord P, Bayliss MT, Neame PJ, Heinegard D: Identification and characterization of asporin A novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J Biol Chem 2001, 276:12201-12211.
8. Sztrolovics R, White RJ, Poole AR, Mort JS, Roughley PJ: Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem J 1999, 339:571-577.
9. Bengtsson E, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A: The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J Biol Chem 2002, 277:15061-15068.
10. Mansson B, Wenglen C, Morgelin M, Saxne T, Heinegard D: Association of chondroadherin with collagen type II. J Biol Chem 2001, 276:32883-32888.
11. Young AA, Smith MM, Smith SM, Cake MA, Ghosh P, Read RA, Melrose J, Sonnabend DH, Roughley PJ, Little CB: Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther 2005, 7:R852-R861.
12. Kizawa H, Kou I, Iida A, Sudo A, Miyamoto Y, Fukuda A, Mabuchi A, Kotani A, Kawakami A, Yamamoto S, et al.: An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 2005, 37 138-144.
13. Bock HC, Michaeli P, Bode C, Schultz W, Kresse H, Herken R, Miosge N: The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis. Osteoarthritis Cartilage 2001, 9:654-663.
14. Melching LI, Roughley PJ: The synthesis of dermatan sulphate proteoglycans by fetal and adult human articular cartilage. Biochem J 1989, 261:501-508.
15. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y: Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 1997, 322:809-814.
16. Winnemoller M, Schon P, Vischer P, Kresse H: Interactions between thrombospondin and the small proteoglycan decorin: Interference with cell attachment. Eur J Cell Biol 1992, 59:47-55.
17. Winnemoller M, Schmidt G, Kresse H: Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol 1991, 54 10-17.
18. Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998, 67:609-652.
19. Poole AR, Rosenberg LC, Reiner A, Ionescu M, Bogoch E, Roughley PJ: Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J Orthop Res 1996, 14:681-689.
20. Heathfield TF, Onnerfjord P, Dahlberg L, Heinegard D: Cleavage of fibromodulin in cartilage explants involves removal of the Nterminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem 2004, 279 6286-6295.
21. Chakravarti S, Stallings RL, SundarRaj N, Cornuet PK, Hassell JR: Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics 1995, 27:481-488.
22. Iozzo RV, Murdoch AD: Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996, 10 598-614.
23. Hocking AM, Shinomura T, McQuillan DJ: Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998, 17:1-19.
24. Grover J, Chen XN, Korenberg JR, Roughley PJ: The human lumican gene Organization, chromosomal location, and expression in articular cartilage. J Biol Chem 1995, 270:21942-21949.
25. Svensson L, Narlid I, Oldberg A: Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett 2000, 470 178-182.
26. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H: Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998, 141 1277-1286.
27. Li Y, Aoki T, Mori Y, Ahmad M, Miyamori H, Takino T, Sato H: Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res 2004, 64:7058-7064.
28. Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itoh Y, Nagase H: Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 2004, 279:10109-10119.
29. Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ: Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996, 380:17-20.
30. Altman RD, Asch E, Bloch DA, Bole G, Borenstein D, Brandt KD, Christy W, Cooke TD, Greenwald R, Hochberg M, et al.: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986, 29:1039-1049.
31. Mankin HJ, Dorfman H, Lippiello L, Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips II Correlation of morphology with biochemical and metabolic data J Bone Joint Surg Am 1971, 53:523-537.
32. Pelletier JP, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis JE, Woessner JF Jr: Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum 1983, 26:63-68.
33. Martel-Pelletier J, Pelletier JP, Cloutier JM, Howell DS, Ghandur-Mnaymneh L, Woessner JF Jr: Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum 1984, 27:305-312.
34. Roughley PJ, White RJ, Poole AR: Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J 1985, 231:129-138.
35. Pelletier JP, Martel-Pelletier J, Cloutier JM, Woessner JF Jr: Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage, and the effect of intraarticular steroid injections. Arthritis Rheum 1987, 30:541-548.
36. Farndale RW, Sayers CA, Barrett AJ: A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982, 9:247-248.
37. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, et al.: Enhanced cleavage of Type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545.
38. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 1996, 271:1544-1550.
39. Scott JE: Proteoglycan: collagen interactions in connective tissues. Ultrastructural, biochemical, functional and evolutionary aspects. Int J Biol Macromol 1991, 13:157-161.
40. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 1997, 378:151-160.
41. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346:281-284.
42. Tardif G, Pelletier JP, Dupuis M, Geng C, Cloutier JM, Martel-Pelletier J: Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiological state of the cells. Arthritis Rheum 1999, 42 1147-1158.
43. Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelletier J: Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: In vitro mimicking effect by transforming growth factor beta. Arthritis Rheum 1997, 40:1653-1661.
44. Svensson L, Heinegard D, Oldberg A: Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5. J Biol Chem 1995, 270:20712-20716.
45. Scott PG, McEwan PA, Dodd CM, Bergmann EM, Bishop PN, Bella J: Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc Natl Acad Sci USA 2004, 101:15633-15638.
46. Kojoh K, Fukuda E, Matsuzawa H, Wakagi T: Zinc-coordination of aspartic acid-76 in Sulfolobus ferredoxin is not required for thermal stability of the molecule. J Inorg Biochem 2002, 89:69-73.
47. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J: The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: A role in osteoarthritis. J Clin Invest 1996, 97:2011-2019.